Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
MPSYF similar filings
- 22 May 20 MorphoSys and Incyte Announce the Validation of the European Marketing Authorization Application for Tafasitamab
- 22 May 20 MorphoSys to Present Data on Tafasitamab at the ASCO and EHA Virtual Meetings
- 15 May 20 MorphoSys and Incyte Announce Long-term Follow-up Results from L-MIND Study of Tafasitamab in Patients with r/r DLBCL
- 8 May 20 MorphoSys Reports First Quarter 2020 Results
- 6 May 20 First Quarter Interim Statement
- 28 Apr 20 MorphoSys andI-Mab Announce First Patient Dosed in Phase 3 Clinical Trial of MOR202/TJ202 in r/r Multiple Myeloma in Mainland China
- 24 Apr 20 MorphoSys Appoints Roland Wandeler, Ph.D., as Chief Commercial Officer
Filing view
External links